Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Operating Expenses (2016 - 2026)

Phibro Animal Health has reported Operating Expenses over the past 14 years, most recently at $82.5 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 3.09% year-over-year to $82.5 million; the TTM value through Dec 2025 reached $298.6 million, up 5.61%, while the annual FY2025 figure was $293.3 million, 12.72% up from the prior year.
  • Operating Expenses for Q4 2025 was $82.5 million at Phibro Animal Health, up from $68.8 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $85.2 million in Q4 2024 and troughed at $48.4 million in Q4 2021.
  • A 5-year average of $62.3 million and a median of $60.6 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: fell 4.75% in 2023 and later surged 35.34% in 2024.
  • Year by year, Operating Expenses stood at $48.4 million in 2021, then increased by 27.21% to $61.5 million in 2022, then increased by 2.23% to $62.9 million in 2023, then surged by 35.34% to $85.2 million in 2024, then fell by 3.09% to $82.5 million in 2025.
  • Business Quant data shows Operating Expenses for PAHC at $82.5 million in Q4 2025, $68.8 million in Q3 2025, and $76.3 million in Q2 2025.